Panama Canal

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?

Representative image of the Panama Canal with container ships, reflecting Panama’s US$20 billion investment drive and new opportunities for Barbados.

Can Barbados leverage its strengths as Panama launches a $20bn investment drive?

Panama’s US$20B investment plan opens doors for Barbados in ports, tourism, energy, and services. Find out why analysts say this could be a turning point.

byPallavi Madhiraju

August 24, 2025

Trump eyes Panama Canal and Greenland: Military action on the table?

President-elect Donald Trump has stirred global debate with his ambitious vision to reclaim control of the Panama Canal…

byPallavi Madhiraju

January 7, 2025

The Latest

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?

Can Barbados leverage its strengths as Panama launches a $20bn investment drive?

Trump eyes Panama Canal and Greenland: Military action on the table?

The hidden problem with GLP-1 weight loss and Veru Inc.’s bet to fix it (NASDAQ: VERU)

GRPN slides after Q4 revenue shortfall raises questions about Groupon’s turnaround durability

Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock

Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026